Recent publications on Cancer
Kerlavage AR, Kirchhoff AC, Guidry Auvil JM, Sharpless NE, Davis KL, Reilly K, Reaman G, Penberthy L, Deapen D, Hwang A, Durbin EB, Gallotto SL, Aplenc R, Volchenboum SL, Heath AP, Aronow BJ, Zhang J, Vaske O, Alonzo TA, Nathan PC, Poynter JN, Armstrong G, Hahn EE, Wernli KJ, Greene C, DiGiovanna J, Resnick AC, Shalley ER, Nadaf S, Kibbe WA Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer 2021 Aug;5:881-896. doi: 10.1200/CCI.21.00040. PubMed
Zhang D, Abraham L, Demb J, Miglioretti DL, Advani S, Sprague BL, Henderson LM, Onega T, Wernli KJ, Walter LC, Kerlikowske K, Schousboe JT, O'Meara ES, Braithwaite D, Breast Cancer Surveillance Consortium Function-related indicators and outcomes of screening mammography in older women: evidence from the Breast Cancer Surveillance Consortium cohort 2021 Aug;30(8):1582-1590. doi: 10.1158/1055-9965.EPI-21-0152. Epub 2021-06-02. PubMed
Lee JM, Ichikawa LE, Wernli KJ, Bowles E, Specht JM, Kerlikowske K, Miglioretti DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016 2021 Aug;300(2):290-300. doi: 10.1148/radiol.2021204581. Epub 2021-05-18. PubMed
Heine J, Fowler E, Scott CG, Jensen MR, Shepherd J, Hruska CB, Winham SJ, Brandt KR, Wu FF, Norman AD, Pankratz VS, Miglioretti DL, Kerlikowske K, Vachon CM Mammographic Variation Measures, Breast Density, and Breast Cancer Risk 2021 Aug;217(2):326-335. doi: 10.2214/AJR.20.22794. Epub 2021-06-23. PubMed
Kerlikowske K, Bissell MCS, Sprague BL, Buist DSM, Henderson LM, Lee JM, Miglioretti DL Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium 2021 Jul;113(7):909-916. doi: 10.1093/jnci/djaa176. PubMed
Marlow EC, Ducore J, Kwan ML, Cheng SY, Bowles EJA, Greenlee RT, Pole JD, Rahm AK, Stout NK, Weinmann S, Smith-Bindman R, Miglioretti DL Leukemia Risk in a Cohort of 3.9 Million Children With and Without Down Syndrome 2021 Jul;234:172-180.e3. doi: 10.1016/j.jpeds.2021.03.001. Epub 2021-03-06. PubMed
DiNucci A, Henrikson NB, Jonas MC, Basra S, Blasi P, Brown J, Esplin ED, Hassen D, Hao J, Hu Y, Klinger T, Ladd I, Leppig K, Lewis M, Meyer M, Ney S, Ramaprasan A, Romagnoli K, Salvati Z, Scrol A, Schwiter R, Sheridan L, Somasundaram B, Suwannarat P, Wagner JK, Rahm AK Feasibility and Assessment of a Cascade Traceback Screening Program (FACTS): Protocol for a Multisite Study to Implement and Assess an Ovarian Cancer Traceback Cascade Testing Program 2021 Jun 11;11(6). doi: 10.3390/jpm11060543. Epub 2021-06-11. PubMed
Michels KA, Geczik AM, Bauer DC, Brinton LA, Buist DSM, Cauley JA, Dallal CM, Falk RT, Hue TF, Lacey JV, LaCroix AZ, Tice JA, Xu X, Trabert B Endogenous progestogens and colorectal cancer risk among postmenopausal women 2021 Jun;30(6):1100-1105. doi: 10.1158/1055-9965.EPI-20-1568. Epub 2021-04-07. PubMed
Abubakar M, Fan S, Bowles EA, Widemann L, Duggan MA, Pfeiffer RM, Falk RT, Lawrence S, Richert-Boe K, Glass AG, Kimes TM, Figueroa JD, Rohan TE, Gierach GL Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk 2021 Jun;5(3). doi: 10.1093/jncics/pkab015. Epub 2021-02-06. PubMed
Sung H, Freedman RA, Siegel RL, Hyun N, DeSantis C, Ruddy KJ, Jemal A. Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status. Cancer. 2021 Sep 15;127(18):3310-3324. doi: 10.1002/cncr.33602. Epub 2021 May 18. PubMed
Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force 2021 May 18;325(19):1978-1998. doi: 10.1001/jama.2021.4417. PubMed
Golmakani MK, Hubbard RA, Miglioretti DL. Non-homogeneous markov chain for estimating the cumulative risk of multiple false positive screening tests. Biometrics. 2021 May 3. doi: 10.1111/biom.13484. [Epub ahead of print]. PubMed
Makhnoon S, Bowen DJ, Shirts BH, Fullerton SM, Larson EB, Ralston JD, Leppig KA, Crosslin DR, Veenstra D, Jarvik GP The FamilyTalk randomized controlled trial: patient-reported outcomes in clinical genetic sequencing for colorectal cancer 2021 May;32(5):483-492. doi: 10.1007/s10552-021-01398-1. Epub 2021-02-16. PubMed
Lewis CC, Hannon PA, Klasnja P, Baldwin LM, Hawkes R, Blackmer J, Johnson A, OPTICC Consortium, represented by Bryan J. Weiner Optimizing Implementation in Cancer Control (OPTICC): protocol for an implementation science center 2021 Apr 23;2(1):44. doi: 10.1186/s43058-021-00117-w. Epub 2021-04-23. PubMed
Farjah F, Monsell SE, Gould MK, Smith-Bindman R, Banegas MP, Heagerty PJ, Keast EM, Ramaprasan A, Schoen K, Brewer EG, Greenlee RT, Buist DSM Association of the Intensity of Diagnostic Evaluation With Outcomes in Incidentally Detected Lung Nodules 2021 Apr;181(4):480-489. doi: 10.1001/jamainternmed.2020.8250. PubMed
Meenan RT, Baldwin LM, Coronado GD, Schwartz M, Coury J, Petrik AF, West II, Green BB Costs of Two Health Insurance Plan Programs to Mail Fecal Immunochemical Tests to Medicare and Medicaid Plan Members 2021 Apr;24(2):255-265. doi: 10.1089/pop.2020.0041. Epub 2020-06-29. PubMed
Malone C, Buist DSM, Tiro J, Barlow W, Gao H, Lin J, Winer RL Out of reach? Correlates of cervical cancer underscreening in women with varying levels of healthcare interactions in a United States integrated delivery system 2021 Apr;145:106410. doi: 10.1016/j.ypmed.2020.106410. Epub 2020-12-31. PubMed
Gould MK, Altman DE, Creekmur B, Qi L, de Bie E, Golden S, Kaplan CP, Kelly K, Miglioretti DL, Mularski RA, Musigdilok VV, Smith-Bindman R, Steltz JP, Wiener RS, Aberle DR, Dyer DS, Vachani A Guidelines for the Evaluation of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Awareness, Agreement, and Adherence From the Watch the Spot Trial 2021 Apr;18(4):545-553. doi: 10.1016/j.jacr.2020.10.003. Epub 2020-11-17. PubMed
Inadomi JM, Issaka RB, Green BB What Multi-Level Interventions Do We Need to Increase the Colorectal Cancer Screening Rate to 80%? 2021 Apr;19(4):633-645. doi: 10.1016/j.cgh.2019.12.016. Epub 2019-12-27. PubMed
Miglioretti DL, Bissell MCS, Kerlikowske K, Buist DSM, Cummings SR, Henderson LM, Onega T, O'Meara ES, Rauscher GH, Sprague BL, Tosteson ANA, Wernli KJ, Lee JM, Lee CI Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity 2021 Mar;4(3):e211974. doi: 10.1001/jamanetworkopen.2021.1974. Epub 2021-03-01. PubMed


